Vortioxetine in the treatment of major depressive disorder
Authors:
- 24 February 2015
- journal article
- Published by Taylor & Francis in Future Neurology
- Vol. 10 (2) , 79-89
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonismEuropean Neuropsychopharmacology, 2014
- Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: Evidence for direct 5-HT receptor modulationEuropean Neuropsychopharmacology, 2014
- Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in miceNeuropharmacology, 2013
- 5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjectsEuropean Neuropsychopharmacology, 2013
- Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive DisorderThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Occupancy of the Serotonin Transporter after Administration of Lu AA21004 and its Relation to Plasma Concentration in Healthy SubjectsBasic & Clinical Pharmacology & Toxicology, 2011
- A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorderInternational Journal of Neuropsychopharmacology, 2011
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive DisorderJournal of Medicinal Chemistry, 2011
- The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behaviorNeuroscience, 2007
- Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography StudyAmerican Journal of Psychiatry, 2004